Objective-Elevated levels of blood leukocytes have been associated with acute coronary events (CEs), but data on leukocyte subclasses are limited. This study aimed to explore whether blood lymphocyte and neutrophil counts are associated with incidence of CEs and with fatal outcome in subjects who subsequently experienced a first CE. Methods and Results-Neutrophil and lymphocyte counts were measured in 27 419 subjects from the general population without a history of CEs, heart failure, or atrial fibrillation. Incidence of CEs was studied in relation to leukocyte counts during a mean follow-up of 13.6 years. Neutrophil but not lymphocyte counts were significantly associated with incidence of CEs. After adjustments for confounding factors, the hazard ratios (95% confidence interval) were 1.00 (reference), 1.07 (0.94 -1.23), 1.09 (0.95-1.25), and 1.39 (1.22-1.59) for subjects with neutrophils in the first, second, third, and fourth (highest) sex-specific quartiles, respectively (P for trend Ͻ0.001). Of the 1965 subject who had a CE, 471 subjects died on the first day of the CE, in-or outside hospital. The proportions of subjects who died the first day were 19%, 21%, 25%, and 28%, respectively in the first, second, third, and fourth quartiles (P for trend Ͻ0.001). Conclusion-Increased neutrophil counts are associated with incidence of CEs and increased case-fatality rate after a CE.
C hronic inflammation is now widely accepted as a central contributor to the pathogenesis of cardiovascular disease (CVD). 1 Different markers of inflammation, including C-reactive protein, interleukin-6, erythrocyte sedimentation rate, fibrinogen, and other acute phase proteins have been associated with coronary events (CEs). [2] [3] [4] [5] [6] Increased leukocyte count is a classic marker of chronic and acute inflammation, reflecting proliferation and recruitment of leukocytes to the vascular system. Elevated leukocyte concentrations have been associated with increased incidence of myocardial infarction and stroke. [7] [8] [9] [10] [11] [12] [13] However, although animal studies have focused extensively on the role of specific cell types in CVD, 1 few human studies have focused on different leukocyte subclasses. Previous studies suggest that neutrophils, reflecting activation of the innate immune system, are more strongly associated with incidence of coronary heart disease (CHD) than lymphocytes, which reflect activation of the adaptive immune system. However, results are contradictory, with substantial heterogeneity across studies. 8, 14 Approximately 30% of men who experience a first acute CE die within the first days, and most of them die suddenly without reaching the hospital. 15 Elevated concentrations of leukocytes have been associated with worse prognosis in subjects with clinically manifest CHD, 5 but there are limited data from population-based studies of case fatality, including cases who died out-of-hospital. It was reported that 5 acute phase proteins were associated with increased fatality in men who experienced a CE, 16 but it remains unknown whether raised concentrations of leukocytes affect the fatality of subsequent CEs.
The purpose of this population-based cohort study was to explore whether blood lymphocyte and neutrophil concentrations are associated with incidence of acute CEs and to explore whether lymphocyte and neutrophil concentrations are associated with fatal outcome in subjects who subsequently experienced a first CE.
Methods

Study Population
All men born between 1923 and 1945 and women born between 1923 and 1950 living in Malmö, Sweden, were invited to participate in the Malmö Diet and Cancer Study. Between March 1991 and September 1996, the respondents participated in clinical examinations at the screening center and a self-administered questionnaire. The cohort consisted of 28 449 subjects (11 246 men and 17 203 women) from the eligible population of Ϸ74 000 individuals. 17 Of them, 849 subjects with a history of CEs, heart failure, or atrial fibrillation were excluded. Another 174 subjects were excluded because of missing data on lymphocytes, neutrophils, body mass index, waist, systolic blood pressure or diastolic blood pressure. Subjects with more than 20ϫ10 9 leukocytes per liter (nϭ13) were also excluded. After exclusions, 27 413 subjects remained, with a mean age of 58Ϯ7.6 years.
The regional ethics committee approved the Malmö Diet and Cancer Study. Participants provided written informed consent. The cohort has been shown to be representative considering smoking and overweight, but with a higher mortality rate in nonparticipants. 17
Baseline Examinations
A self-administered questionnaire was used to obtain information on smoking habits, diabetes, antihypertensive medication, lipidlowering medication, marital status, education level, and history of myocardial infarction. Smoking was divided into 4 different categories: smokers, former smokers, nonsmokers, and missing. Marital status was classified into 3 groups: unmarried (single, divorced, or widowed), married (cohabiting), and missing. Educational level was divided into low (Յ8 years), moderate (9 -12 years), and high (college/university) levels.
Blood pressure was measured using a mercury-column sphygmomanometer after 10 minutes of rest in the supine position. Hypertension was defined as systolic blood pressure Ն140/90 mm Hg or use of antihypertensive medication.
Information on daily alcohol intake was assessed through a validated diet history method where food and beverages was registered in a "menu book" on 7 consecutive days. 18 Daily alcohol consumption in men/women was classified as low (Ͻ20/Ͻ15 g/day), medium (20 -40/15-30 g/day), and high (Ͼ40/Ͼ30 g/day).
Body weight, height, and waist circumference were measured. Diabetes mellitus was defined as self-reported diabetes according to the questionnaire or treatment with antidiabetic medication.
Information on physical activities was explored through 18 questions covering a range of activities in the 4 seasons. An overall leisure time physical activity score was created by multiplying the number of minutes per week for each activity by an intensity coefficient. The scores were divided into quartiles of physical activity when used in the analysis.
Total and differential leukocyte count (neutrophils, lymphocytes, and mixed cells, the latter including monocytes, eosinophils, and basophils) was counted using a SYSMEX K1000 automatic counter (Sysmex Europe, Norderstedt, Germany). The analyses were performed consecutively at the time of the screening examination, at the central laboratory of Malmö Hospital, using fresh heparinized blood.
Follow-Up and Definition of End Points
Subjects were followed from the baseline examination until a first CE, death, emigration from Sweden, or end of follow-up (December 31, 2008).
A CE was defined as a hospital diagnosis of acute myocardial infarction (International Classification of Diseases code 410 or I21) or death due to ischemic heart disease (410 -414 or I20 -I25). Case-fatality rates during the first day include those who died outside hospital or in-hospital on the day of the CE. Case fatality rates within 28 days include out-of-hospital deaths and deaths within 28 days after hospitalization.
Of the 471 patients who died within the first day, cause of death was based on autopsy in 304 patients (65%). Of the remaining 167, cause of death was based on examinations in hospital before death for 116 patients, on findings from examinations outside hospital before death for 21 patients, and on other sources for 30 patients.
The Swedish hospital discharge register and the Swedish Cause of Death register were used for case retrieval. 19
Statistics
One-way analysis of variance and logistic regression was used to compare risk factor distributions across sex-specific quartiles of leukocyte subclasses. Cox proportional hazards regression was used to estimate hazard ratios (HRs) adjusted for potential confounding factors. The fit of the proportional hazards model was confirmed by plotting the incidence rates over time. The model was adjusted for cardiovascular risk factors associated with leukocyte subclasses at baseline. Age, waist circumference, and systolic blood pressure were fitted as continuous variables. Diabetes, antihypertensive medication, lipid-lowering medication, and high alcohol consumption were fitted as dichotomous variables. For some individuals, information was missing about smoking (nϭ307, 1.1%), marital status (nϭ312, 1.1%), and physical activity (nϭ478, 1.7%). These individuals were coded into separate categories to keep them in the multivariate analysis.
The Kaplan-Meier estimator and log-rank test was used to study incidence of CEs across quartiles of neutrophils and crude survival rates after a first CE across quartiles of neutrophils. Logistic regression, with fatal CEs versus nonfatal CEs as the dependent variable, was used to study the relationship between blood cell concentrations and fatal outcome after adjustment for potential confounders. Interactions between major biological risk factors (ie, age, sex, smoking, hypertension, diabetes) and leukocyte counts on incidence of CE events were tested by entering interaction terms in the Cox models.
All analyses were performed in SPSS version 17 or in PASW Statistics 18 (SPSS Inc, Chicago, IL).
Results
Baseline Characteristics
The mean values of neutrophil count at baseline examination were 3.9Ϯ1.3ϫ10 9 cells/L (interquartile range 3.0 -4.5, range 0.6 -15.4) in men and 3.9Ϯ1.3ϫ10 9 cells/L (interquartile range 3.0 -4.5, range 0.2-14.9) in women.
The relationships between sex-specific quartiles of neutrophils and cardiovascular risk factors are presented in Table 1 . The corresponding data for lymphocytes are shown in Supplemental Table I , available online at http://atvb.ahajournals.org. High neutrophil counts were associated with age, smoking, diabetes, body mass index, waist circumference, systolic and diastolic blood pressure, antihypertensive medication, lipidlowering medication, low physical activity, single marital status, and low education level.
Incidence of CEs in Relation to Neutrophil Counts
During a mean follow-up of 13.6 years, 1965 subjects (1245 men, 720 women, 5.3 per 1000 person-years) experienced a fatal or nonfatal CE. Incidence of CEs was significantly associated with neutrophil count ( Neutrophil count was associated both with incidence of fatal CEs (first day) (adjusted HR, 1.77; CI, 1.34 -2.34 for Q4 versus Q1) and incidence of nonfatal CEs (surviving 28 days) (HR, 1.28; CI, 1.01-1.50).
Incidence of CEs in Relation to Lymphocytes and Mixed Cells
Incidence of CEs was significantly associated with lymphocyte counts (Table 3 ). However, the relationship was attenu-ated and did not reach significance after adjustment for potential confounding factors.
Incidence of CEs was significantly associated with mixed leukocyte count ( Table 4 ). The relationship remained significant after adjustment for potential confounding factors.
Interactions
Neutrophils showed a significant positive interaction with smoking (Pϭ0.02) on incidence of CEs. Neutrophil count was significantly associated with CEs in all subgroups of smoking except those with missing information on smoking. HRs were higher among smokers compared with nonsmokers ( Supplemental Table II ). Neutrophils showed no significant interactions with age, sex, diabetes, or systolic blood pressure.
Lymphocytes showed significant positive interactions with smoking (PϽ0.001) and systolic blood pressure (Pϭ0.007) on incidence of CEs. In subgroup analyses, HRs were significant only for regular smokers and those with missing information on smoking. Lymphocytes showed no significant interaction with age, sex, or diabetes.
Case Fatality Rates
Of the 1965 subjects with CEs, 471 subjects (24%, 319 men and 152 women) died on the first day, and another 87 subjects (4%, 55 men and 32 women) died within 28 days. Of those who died on the first day, cause of death was determined on the basis of autopsy in 65% of the cases.
After adjustment for cardiovascular risk factors, case fatality rate (within 1 day or within 28 days) was significantly associated with increased neutrophil count at baseline (Pϭ0.02 and Pϭ0.01, respectively) ( Table 5 ). This relationship was consistent for cases with cause of death established at autopsy and for those with cause of death from other sources ( Supplemental Table III ). Figure 2 shows case-fatality rates in relation to quartiles of neutrophil count at baseline examination. Case-fatality rates were not associated with lymphocyte count or mixed leukocyte count.
Discussion
Leukocyte count is a commonly used marker of inflammation. Several studies have suggested an association be- tween elevated leukocyte count and CHD-related morbidity and mortality. 20 Most studies, however, were performed in patients with established CVD, and few populationbased studies have explored incidence of CVD in relation to differential cell counts. The present study showed that elevated levels of neutrophils and lymphocytes were associated with incidence of CEs. After adjustments for other cardiovascular risk factors, the association with neutrophils remained significant. Elevated levels of neutrophils were also significantly associated with increased case-fatality rates after future CEs. The relationship was seen when studying both death during the first day and death within 28 days, and it remained significant after adjustments for potential confounding factors. Hence, the neutrophil count was associated with both increased incidence of CEs and events of higher severity. No relationship was seen between lymphocyte counts and casefatality rates.
Our results were in accordance with results from the EPIC-Norfolk Prospective Population Study, which con-cluded that the higher risk for CHD and CVD associated with increased total leukocyte count was accounted for by an increased granulocyte count. 9 Other studies suggested that only granulocytes or neutrophils were associated with increased cardiovascular risk 10 -12,21 or that neutrophils showed the strongest association. 8 One smaller study suggested monocytes but not neutrophils to be associated with increased risk of CHD, 14 whereas another study showed increased risks for both monocytes and granulocytes. 22 The automatic cell counter in the present study did not differentiate among monocytes, basophils, and eosinophils, which is a limitation of our study. However, the category of mixed cells consists mainly of monocytes, and the significant relationship between mixed cells and CEs therefore supports the view that monocytes also are associated with CEs.
Although the neutrophils were significantly associated with incidence of CEs and case fatality, there were no clear relationship between lymphocytes and CEs. Even though neutrophils are an important component of the innate immunity and the acute inflammatory response, they are often regarded as less important for the development of atherosclerosis. However, recent research indicates that neutrophils could have an important role in atherogenesis and development of plaque instability. 23 For lymphocytes and the adaptive immunity, on the other hand, there is a widely accepted relationship with atherogenesis. However, the function is very different for the various subsets of lymphocytes. It is therefore reasonable to assume that the proportions of the lymphocyte subtypes could be more important than the total number. 24 To our knowledge, no other population-based study has reported case-fatality rates after future CEs in relation to leukocyte counts. Other factors previously reported to be associated with increased case fatality in population-based studies are smoking, 25 diabetes, 26 hypertension, 25, 27, 28 physical inactivity, 28 and marital status. 29 Leukocytes, and particularly neutrophils, were correlated with several of these risk factors in our study, but the association with case fatality remained after adjustment for these factors.
Improved treatment during the acute phase has substantially reduced the hospital mortality rates for patients with a first acute coronary syndrome. However, the out-of-hospital mortality rates are still high. 15 To further reduce the mortality rates, it is necessary to develop tools for early identification and treatment of individuals with high risk of CEs in general and especially those with high risk of fatal CEs. This is obviously a major challenge for public health. Besides hypertension, there is no modifiable risk factor with a well-documented relationship with case fatality in population-based settings. The magnitude of the relationships between neutrophils and the outcomes was moderate in this study, and it remains to be evaluated whether the effect size could be stronger for other inflammatory markers. However, as neutrophils were associated with incidence of CEs as well as increased case fatality, it is conceivable that measures of inflammation could contribute to the identification of individuals with increased risk, especially for events with fatal outcome. Several mechanisms by which neutrophils might influence risk of CHD can be suggested. Neutrophils have been detected in atherosclerotic plaques, 1 and might increase risk of plaque rupture and thrombosis by causing proteolytic vascular damage, 30 vessel plugging, 31 or activation of the coagulation system. 32, 33 It is conceivable that these mechanisms also affect mortality after CEs.
Leukocytes have also been shown to affect the electric stability of the heart. 34, 35 The fact that high leukocyte count may predict ventricular fibrillation after an acute myocardial infarction suggests a possible link between neutrophils and case-fatality rates. Oxygen free radicals are believed to be a cause of ventricular arrhythmias. Activated leukocytes have been shown to release such radicals. 36 The end points of this study were retrieved using the Swedish hospital discharge register. A validation study from this register has shown that a diagnosis of myocardial infarction is correct in 95% of the patients. 37 The autopsy rates are very high.
All patients in this study were without a history of myocardial infarction at baseline examination, according to hospital registers and self-report. The registered acute CEs in this study were thus first clinically apparent events. Because electrocardiographic information at baseline was not available, we were not able to detect patients with a history of silent myocardial infarction. This is a limitation of this study.
Another limitation is that information about blood lipids was unavailable. Cholesterol levels have previously been shown to correlate with leukocyte count. 13, 38 Lipid-lowering treatment was used as a crude proxy for raised lipid levels in this study. However, even though raised lipid levels is a major cardiovascular risk factor and high lipids predict adverse outcome in patients hospitalized for an acute CE, it is controversial whether high lipids are associated with case fatality in population-based studies of subjects with future CEs. 25, 28 Other questions are whether the leukocyte concentration could have changed during the mean follow-up of 13.6 years and to what extent this could have changed the results. A substantial proportion of the leukocyte concentrations seem to be genetically determined, and the polygenic heritability for leukocyte counts has been estimated to 35%. 37 Studies with repeated measurements indicate that the concentrations are rather stable over time. 39 If anything, changed leukocyte concentrations would reduce the HRs and bias the results toward null.
In conclusion, the present study establishes that high neutrophil counts are associated with incidence of CEs and with increased case-fatality rates in future CEs.
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